
(Credit-Canva)
With the extra busy schedules people have these days, fitness tracking apps have helped many people time and track their exercise time, calories burnt and the time taken to do so. These apps also remind us to drink water, not exceed our calorie limits for the day, as well as keep exercising. However, sometimes these devices can have an adverse impact on our health. Instead of making us feel better, they can make us feel anxious or stressed. This generally happens when we become too focused on the numbers and start to worry if they aren't perfect. It's important to understand that while these trackers can be helpful, they shouldn't control our mood or make us feel bad about ourselves.
A recent study published in the Journal of the American Heart Association also found that people with heart problems who used trackers were more worried about their symptoms. With so many people using these devices, it's becoming a common problem. 20% of wearable users felt anxious and always contacted their doctors when they received an irregular rhythm notification. They also found that these devices meant increased monitoring and worrying, higher usage of AFib (atrial fibrillation) specific health care etc. These findings suggest that while wearables can help patients monitor their AFib, they may also lead to increased anxiety and health care use. More research is needed to fully understand the effects of these devices on patients, doctors, and the health care system.
We can become too focused on achieving certain goals, like a certain number of steps or a perfect sleep score. This can lead to stress and anxiety when we don't meet those goals, instead of simply using the information to support a healthy lifestyle.
If your happiness or sadness depends on the numbers your fitness tracker shows, it's a sign you might need a break. Getting a low score can make you feel like you've failed, even if you've been making healthy choices. It's normal to feel a little disappointed when you don't reach a goal, but your overall mood shouldn't be affected. If you notice that your mood changes a lot based on your tracker's data, it might be time to step away from it for a while.
If you find yourself constantly searching online to understand what your tracker's data means, it's a warning sign. Trying to interpret every number can lead to more worry and confusion. You might start to believe you have health problems that don't exist. It's important to remember that these trackers are tools, not medical professionals. Spending too much time trying to decode the data can increase your anxiety instead of helping you.
If you feel nervous or anxious when you forget your tracker or it's not working, you might be too dependent on it. You should be able to feel comfortable and relaxed without constant data. If you feel panicky when you can't see your numbers, it's a sign you need to learn to be okay without them. You should be able to trust your body's signals instead of relying only on the tracker.
If you rely only on your tracker and ignore what your body is telling you, it's a problem. Your body's signals are important. For example, you might feel well-rested, but if your tracker says your sleep quality is low, you might start to doubt yourself. It's important to listen to your body and not just the numbers. Your body knows when it's tired, hungry, or needs rest. The tracker is a tool to support your health, not replace your body’s signals.
Anaemia associated with thalassemia itself may increase fatigue and reduce oxygen supply to both mother and baby if not carefully monitored. (Photo credit: iStock)
Thalassemia, particularly thalassemia major and thalassemia intermediate, can affect fertility and pregnancy due to iron overload caused by repeated blood transfusions. In these patients, excess iron gets deposited in various endocrine and vital organs, leading to hormonal disturbances and fertility-related complications.
Patients with thalassemia major usually require regular blood transfusions for survival, sometimes every one to three months. Thalassemia intermediate patients may require fewer transfusions, but they too remain at risk of iron overload. Over time, excess iron can accumulate in organs such as the pituitary gland, thyroid, ovaries, kidneys, liver, and suprarenal glands. This iron deposition can impair hormonal function and contribute to infertility. Experts note that many patients with thalassemia major may face fertility issues because of this reason.
Dr. Sunil Bichile, Hematologist, Saifee Hospital, Mumbai, said, "Although thalassemia management has improved significantly over the years, pregnancy in such patients is still considered high-risk. " Even when iron levels are properly managed, risks to both the mother and fetus may still exist. However, these complications are mainly seen in thalassemia major and thalassemia intermediate patients. Individuals with thalassemia minor generally do not face these fertility or pregnancy-related issues and can have normal pregnancies."
"Doctors also emphasise the importance of carrier screening and prenatal diagnosis. If both partners are thalassemia carriers, prenatal testing around 12 weeks of pregnancy can help determine whether the fetus has thalassemia major. Early diagnosis allows families and doctors to make informed medical decisions and helps reduce severe thalassemia cases," Dr Bichile added.
Women with thalassemia are now increasingly able to experience healthy pregnancies due to advances in medical care. However, one of the most important concerns during pregnancy in thalassemia patients is iron overload—a condition caused by repeated blood transfusions over many years. Excess iron gets deposited in vital organs such as the heart, liver, and endocrine glands, potentially leading to serious complications if not managed properly before conception and during pregnancy.
"Iron overload can significantly increase pregnancy-related risks. When excess iron affects the heart, it may lead to cardiac complications such as arrhythmias or heart failure, which can worsen during pregnancy because of the increased workload on the cardiovascular system. Iron deposition in endocrine glands may also cause hormonal imbalances, affecting fertility and increasing the risk of gestational diabetes, thyroid disorders, or difficulties in maintaining a healthy pregnancy," Dr Liza Bulsara, Pediatric Hematologist and Oncologist, Ruby Hall Clinic, Pune, explained.
Women with poorly controlled iron overload may face a higher chance of miscarriage, fetal growth restriction, preterm delivery, or complications during childbirth. In some cases, liver dysfunction caused by iron accumulation can further complicate pregnancy management. Additionally, anaemia associated with thalassemia itself may increase fatigue and reduce oxygen supply to both mother and baby if not carefully monitored.
Dr Bulsara emphasised that pre-pregnancy counselling is essential for women with thalassemia. A detailed assessment of iron levels through serum ferritin tests and MRI evaluation of the heart and liver helps doctors determine whether the body is prepared for pregnancy. Proper iron chelation therapy before conception plays a crucial role in reducing excess iron stores and improving maternal outcomes. During pregnancy, transfusion schedules, haemoglobin levels, cardiac health, and fetal growth require close multidisciplinary monitoring.
For thalassemia major child only, curative treatment is Allogeneic Stem cell transplant. (Photo credit: AI generated)
Thalassemia is a hereditary illness that hampers the production of haemoglobin, the component of red blood cells that carries oxygen throughout the body. If the production of haemoglobin is faulty or reduced, a shortage of healthy red blood cells occurs, resulting in anaemia and reduced oxygen supply to the organs.
"Thalassemia is, in fact, a collection of conditions ranging from a simple carrier state with no symptoms to a very severe disease requiring lifelong treatment. Mostly, thalassemias are classified into alpha and beta types, depending on which chain of the haemoglobin molecule is defective," said Dr Sneha Shinde, Consultant – Paediatric Haemato-Oncology, P.D. Hinduja Hospital and MRC Centre, Khar.
As per National Health Mission figures, nearly 42 million people in India are beta thalassemia carriers, and about 10,000 to 15,000 infants with thalassemia major are born every year.
This disease is inherited from parents through genes. If both parents are carriers, their child may develop a severe type of the disease.
Symptoms largely depend on the severity of the illness and can include tiredness, weakness, pale complexion, difficulty breathing, stunted growth, enlarged spleen or liver, and changes in facial bones. Most severe cases become apparent during infancy or the toddler years.
Dr Shashikant Apte, Director – Haematology, Sahyadri Super Speciality Hospital, Nagar Road, said, "Symptoms can vary from person to person. Some individuals may simply feel low on energy, while others may notice pale skin, shortness of breath, or delayed growth in children. Because these signs are common, they are often ignored or mistaken for general weakness. The majority of children with thalassemia major require blood transfusions every month for the rest of their lives to maintain haemoglobin levels above 9 gm%."
Dr Shinde explained that diagnosis comprises blood tests such as Complete Blood Count (CBC), HPLC haemoglobin electrophoresis, and genetic analyses. Mild cases may hardly need treatment, but more serious or transfusion-dependent thalassemia cases usually require regular blood transfusions along with iron chelation therapy to avoid iron overload. Besides bone marrow transplantation and newly discovered gene therapies, treatment advancements are gradually leading to better patient survival and improved quality of life.
Dr Apte said, "The positive aspect is that thalassemia can be detected with a simple blood test. Early diagnosis helps in managing the condition more effectively. Therefore, it is advisable to undergo screening for thalassemia before marriage or before planning a pregnancy, so the level of risk can be assessed. If both parents are thalassemia minor carriers, DNA testing should be conducted to identify the genetic defect and enable prenatal diagnosis during the 12th week of pregnancy. If the child is diagnosed with thalassemia major, pregnancy termination may be considered between the 14th and 16th week, based on medical advice and individual circumstances."
Of equal significance is the fact that thalassemia can be prevented through premarital or pre-pregnancy carrier detection and genetic counselling. Early awareness, proper diagnosis, and making informed reproductive choices are the key factors in reducing the burden of this lifelong blood disorder.
Dr Shashikant Apte, Director – Haematology, Sahyadri Super Speciality Hospital, Nagar Road, spoke about the incidence of constant fatigue and answered FAQs about thalassemia major, while sharing tips on living with it.
Being tired every day is typically attributed to a busy lifestyle; however, it can also have underlying medical reasons. Thalassemia is one of the conditions a person is born with that can cause fatigue due to a lack of oxygen. Thalassemia is a disorder in which the proper formation of haemoglobin — the protein in blood responsible for carrying oxygen — does not occur correctly. When haemoglobin is not formed properly, the body does not receive enough oxygen, leading to frequent tiredness and weakness.
Thalassemia major is an inherited disorder, meaning it is passed down from both parents to their child. Some individuals may simply be carriers without displaying any symptoms. During each pregnancy, there is a 25 per cent chance of passing the abnormal gene to the foetus, which may result in severe complications related to thalassemia major or other conditions associated with a lack of oxygen. Therefore, it is critical to know your family’s medical history and thalassemia minor (carrier) status.
Dr Apte went on to say that although thalassemia is a chronic condition, there are highly effective ways to manage it with proper medical guidance. Regular medical check-ups and prompt treatment can help individuals maintain good overall health and lead a normal life.
Understanding thalassemia is the first step towards prevention and better management. Awareness allows individuals and families to make informed decisions and avoid complications before the condition becomes severe.
Credit: AI generated image
World Thalassemia Day is observed every year on May 8 to raise awareness about the inherited blood disorder caused by faulty genes.
The day was initiated in 1994 by the Thalassaemia International Federation in memory of George Englezos, the son of the federation’s founder, who succumbed to the disease.
This year’s theme, “Together for Better Care and Equal Access,” highlights the need for universal screening, safe blood availability, and advanced therapies.
The disorder, which often requires blood transfusions every fortnight, affects approximately 1.3 million people living with severe forms of thalassemia worldwide. About 1.5 percent of the global population is carriers, and the disease claims nearly 11,000 lives annually.
More than 40,000 infants are born each year with severe thalassemia, predominantly in low- and middle-income countries. Although mortality rates have declined, they remain high in developing regions, particularly in Southeast Asia.
Thalassemia is an inherited hemoglobin disorder caused by defective synthesis of alpha or beta globin chains.
In β-thalassemia major, reduced or absent beta-chain production leads to ineffective erythropoiesis, severe anemia, bone marrow expansion, splenomegaly, growth retardation, and iron overload due to repeated blood transfusions.
Patients often present in early childhood with pallor, jaundice, recurrent infections, and characteristic facial bone deformities.
With 10,000–15,000 babies born with Thalassemia Major every single year in India, the country remains one of the global hotspots for the blood transfusion-dependent disease.
HealthandMe spoke to doctors who emphasized that carrier screening, premarital counseling, and antenatal diagnosis remain crucial preventive strategies in India, often referred to as the “thalassemia capital of the world”, as nearly one in every eight thalassemia patients globally lives in the country.
Experts stressed that normalizing conversations around screening is key to reducing the disease burden.
Dr. Ajay Sharma, Director and Head of Hematology and Hemat-Oncology at Paras Health Panchkula, said thalassemia is a preventable genetic disorder, but continues to go undetected until it is too late.
This is because “thalassemia screening, which is one of the simplest yet most overlooked preventive steps in India,” said Dr. Vishnu Hari, Associate Director and Head of Haematology & BMT at Sarvodaya Hospital, Faridabad.
“Every couple, especially those planning marriage or pregnancy, should undergo basic carrier screening. The challenge is not the availability of tests, but the lack of awareness and social hesitation around genetic conditions,” Dr. Hari said.
Also read: Reused Syringes Infect Over 330 Children in Pakistan With HIV: Report
Screening should ideally be done early, as early detection helps informed decision-making and prevents severe health complications in children. Experts recommend screening:
Carrier detection is possible with a complete blood count and a test called High Performance Liquid Chromatography (HPLC). Indicators include:
“If both partners are carriers, timely genetic counselling during the antenatal phase becomes critical,” he said.
While cultural stigma and low prioritization of preventive healthcare often delay this step, the integration of routine thalassemia screening into premarital check-ups and early pregnancy care can help significantly reduce the number of affected births in India.
Dr Parveen Yograj, a General Surgeon from Jammu, in a post on the social media platform X, shared that treatment for thalassemia has evolved remarkably over recent decades.
“Regular blood transfusions combined with iron chelation therapy using agents like Deferasirox and Deferiprone have significantly improved survival. Curative therapy through bone marrow transplantation is now increasingly successful, especially in children with matched donors.
"Recent breakthroughs in gene therapy and CRISPR-based genome editing offer new hope for a long-term cure by correcting defective globin gene expression,” he said.
© 2024 Bennett, Coleman & Company Limited